Relationship between camazepam, N-methyl-oxazepam brain concentrations and antileptazol effect in the rat

S. Caccia, M. Ballabio, S. Garattini

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Camazepam (7-chloro-3-N,N-dimethylcarbamoyloxy-s-phenyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one) has the pharmacological profile of an anxiolytic agent with a clear separation between anxiolytic action and sedative-depressive side effects. Studies of the metabolism of camazepam indicate that the compound is excreted in the urine of several animal species, partly free and partly as N-methyl-oxazepam and oxazepam glucuronides. N-Methyl-oxazepam and oxazepam are pharmacologically active metabolites and may be considered possible contributors to the central nervous system activity of the parent compound. This hypothesis was investigated in the present experiments by comparing brain concentrations of N-methyl-oxazepam and oxazepam after administration of the two metabolites or of camazepam at doses effective against leptazol (pentetrazole) induced convulsions. These findings indicate that the anti-leptazol activity of oral camazepam in the rat is dependent more on the brain concentrations of active metabolites than on the parent compound. However, these conclusions only concern the antileptazol activity of camazepam in the rat. Further studies are needed to see how much the metabolites contribute to other pharmacological effects of camazepam.

Original languageEnglish
Pages (from-to)185-187
Number of pages3
JournalJournal of Pharmacy and Pharmacology
Volume33
Issue number3
Publication statusPublished - 1981

Fingerprint

Oxazepam
Brain
Anti-Anxiety Agents
Pharmacology
Pentylenetetrazole
Hypnotics and Sedatives
camazepam
Seizures
Central Nervous System
Urine

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Relationship between camazepam, N-methyl-oxazepam brain concentrations and antileptazol effect in the rat. / Caccia, S.; Ballabio, M.; Garattini, S.

In: Journal of Pharmacy and Pharmacology, Vol. 33, No. 3, 1981, p. 185-187.

Research output: Contribution to journalArticle

@article{b471ac4d28a34cf0a371893504099b45,
title = "Relationship between camazepam, N-methyl-oxazepam brain concentrations and antileptazol effect in the rat",
abstract = "Camazepam (7-chloro-3-N,N-dimethylcarbamoyloxy-s-phenyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one) has the pharmacological profile of an anxiolytic agent with a clear separation between anxiolytic action and sedative-depressive side effects. Studies of the metabolism of camazepam indicate that the compound is excreted in the urine of several animal species, partly free and partly as N-methyl-oxazepam and oxazepam glucuronides. N-Methyl-oxazepam and oxazepam are pharmacologically active metabolites and may be considered possible contributors to the central nervous system activity of the parent compound. This hypothesis was investigated in the present experiments by comparing brain concentrations of N-methyl-oxazepam and oxazepam after administration of the two metabolites or of camazepam at doses effective against leptazol (pentetrazole) induced convulsions. These findings indicate that the anti-leptazol activity of oral camazepam in the rat is dependent more on the brain concentrations of active metabolites than on the parent compound. However, these conclusions only concern the antileptazol activity of camazepam in the rat. Further studies are needed to see how much the metabolites contribute to other pharmacological effects of camazepam.",
author = "S. Caccia and M. Ballabio and S. Garattini",
year = "1981",
language = "English",
volume = "33",
pages = "185--187",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "3",

}

TY - JOUR

T1 - Relationship between camazepam, N-methyl-oxazepam brain concentrations and antileptazol effect in the rat

AU - Caccia, S.

AU - Ballabio, M.

AU - Garattini, S.

PY - 1981

Y1 - 1981

N2 - Camazepam (7-chloro-3-N,N-dimethylcarbamoyloxy-s-phenyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one) has the pharmacological profile of an anxiolytic agent with a clear separation between anxiolytic action and sedative-depressive side effects. Studies of the metabolism of camazepam indicate that the compound is excreted in the urine of several animal species, partly free and partly as N-methyl-oxazepam and oxazepam glucuronides. N-Methyl-oxazepam and oxazepam are pharmacologically active metabolites and may be considered possible contributors to the central nervous system activity of the parent compound. This hypothesis was investigated in the present experiments by comparing brain concentrations of N-methyl-oxazepam and oxazepam after administration of the two metabolites or of camazepam at doses effective against leptazol (pentetrazole) induced convulsions. These findings indicate that the anti-leptazol activity of oral camazepam in the rat is dependent more on the brain concentrations of active metabolites than on the parent compound. However, these conclusions only concern the antileptazol activity of camazepam in the rat. Further studies are needed to see how much the metabolites contribute to other pharmacological effects of camazepam.

AB - Camazepam (7-chloro-3-N,N-dimethylcarbamoyloxy-s-phenyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one) has the pharmacological profile of an anxiolytic agent with a clear separation between anxiolytic action and sedative-depressive side effects. Studies of the metabolism of camazepam indicate that the compound is excreted in the urine of several animal species, partly free and partly as N-methyl-oxazepam and oxazepam glucuronides. N-Methyl-oxazepam and oxazepam are pharmacologically active metabolites and may be considered possible contributors to the central nervous system activity of the parent compound. This hypothesis was investigated in the present experiments by comparing brain concentrations of N-methyl-oxazepam and oxazepam after administration of the two metabolites or of camazepam at doses effective against leptazol (pentetrazole) induced convulsions. These findings indicate that the anti-leptazol activity of oral camazepam in the rat is dependent more on the brain concentrations of active metabolites than on the parent compound. However, these conclusions only concern the antileptazol activity of camazepam in the rat. Further studies are needed to see how much the metabolites contribute to other pharmacological effects of camazepam.

UR - http://www.scopus.com/inward/record.url?scp=0019429360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019429360&partnerID=8YFLogxK

M3 - Article

C2 - 6116765

AN - SCOPUS:0019429360

VL - 33

SP - 185

EP - 187

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 3

ER -